Considering that cardiometabolic risk factors that form the metabolic syndrome are interrelated (Alberti et al., 2009), the CYP17A1 SNPs may also be associated with elevated fasting blood glucose and the presence of dyslipidemia, but this hypothesis is yet to be tested. This evidence concerns the gene CYP17A1 and metabolic syndrome.